| Spiliopoulos, Stavros |
| Recruiting | 3 | 200 | Europe | Cilostazol, Aspirin | Attikon Hospital, University Hospital of Patras | Peripheral Arterial Disease | 12/21 | 12/21 | | |
SAVE, NCT04327609: Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications |
|
|
| Active, not recruiting | N/A | 84 | Europe, RoW | SELUTION SLR™ DEB, Control Arm | M.A. Med Alliance S.A. | AV Fistula | 02/24 | 12/25 | | |
NCT06330688: Prospective Evaluation of Ultrasound-guided Percutaneous Cholecystostomy With the Trocar Technique |
|
|
| Recruiting | N/A | 100 | Europe | percutaneous cholecystostomy | Attikon Hospital | Cholecystitis, Acute, Cholecystitis | 03/26 | 06/26 | | |
STELA, NCT06119100: Correlation of Ultrasonographic Lesion Type Characterization With Angioplasty Outcomes in Failing Dialysis AVFs |
|
|
| Recruiting | N/A | 200 | Europe | Ultrasound characterization of stenotic lesion type | Attikon Hospital | Dialysis Access Malfunction | 11/24 | 12/24 | | |
| Dimitriadis, Georgios |
ACNH, NCT06435611: Adiposity, Cardiometabolic and Neurocognitive Health Among Ethnic Groups: a Feasibility and Pilot Study |
|
|
| Recruiting | N/A | 10 | Europe | | King's College Hospital NHS Trust | Metabolic Disease, Obesity, Hepatic Steato-Fibrosis, Cardiovascular Diseases, Cognitive Impairment | 12/23 | 06/24 | | |
NCT03878706: The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination |
|
|
| Recruiting | N/A | 240 | Europe | | University of Athens | Diabetes Mellitus, Type 2 | 12/26 | 06/27 | | |
NCT06440122: The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs) |
|
|
| Recruiting | N/A | 100 | Europe | FDG-PET Scan | King's College Hospital NHS Trust | Pheochromocytoma, Paraganglioma | 09/24 | 12/24 | | |
| Lambadiari, Vaia |
NCT05404295: The Effect of Treatment With Umbilical Cord Blood Platelet Lysate on Diabetic Foot Ulcers |
|
|
| Completed | 4 | 120 | Europe | Umbilical cord blood platelel lysate gel | Attikon Hospital, Biomedical Research Foundation, Academy of Athens | Diabetic Foot | 06/22 | 03/23 | | |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
ACHIEVE-4, NCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk |
|
|
| Active, not recruiting | 3 | 2749 | Europe, US, RoW | Orforglipron, LY3502970, Insulin Glargine | Eli Lilly and Company | Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease | 09/25 | 01/26 | | |
| Active, not recruiting | 3 | 15374 | Europe, Canada, Japan, US, RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Obesity, Overweight | 10/27 | 10/27 | | |
NCT05941910: The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function |
|
|
| Recruiting | 2 | 60 | Europe | Q10 | Attikon Hospital | Non-Alcoholic Fatty Liver Disease | 08/23 | 12/23 | | |
NCT04469582: The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors |
|
|
| Active, not recruiting | N/A | 113 | Europe | | University of Athens | Bullous Pemphigoid | 09/20 | 12/20 | | |
NCT06301191: The Effect of Semaglutide on Cardiovascular Markers and Liver Function |
|
|
| Recruiting | N/A | 50 | Europe | Semaglutide, 1.0 mg/mL, Dipeptidyl Peptidase 4 inhibitor | Attikon Hospital | Diabetes Type 2 | 03/23 | 05/24 | | |
NCT03878706: The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination |
|
|
| Recruiting | N/A | 240 | Europe | | University of Athens | Diabetes Mellitus, Type 2 | 12/26 | 06/27 | | |
NCT06646107: Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There a Difference |
|
|
| Not yet recruiting | N/A | 240 | Europe | MInimed 780G | Attikon Hospital | Type1diabetes | 08/25 | 01/26 | | |
| Ikonomidis, Ignatios |
NCT02144857: Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis |
|
|
| Recruiting | 4 | 200 | Europe | etanercept, Enbrel, ustekinumab, Stelara, cyclosporine, Neoral, Secukinumab, Cosentyx, Apremilast, Otezla | University of Athens | Psoriasis | 09/23 | 12/23 | | |
NCT04469582: The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors |
|
|
| Active, not recruiting | N/A | 113 | Europe | | University of Athens | Bullous Pemphigoid | 09/20 | 12/20 | | |
NCT04646252: The Role of Glycocalyx Integrity in the Primary Prevention of Major Cardiovascular Events |
|
|
| Recruiting | N/A | 500 | Europe | Perfused Boundary Region of sublingual microvessels, pulse wave velocity, pulse wave analysis | University of Athens | Endothelial Dysfunction, Arterial Stiffness | 06/26 | 05/27 | | |
NCT04520126: Effect of Olivomed (Olive Extract) on Endothelial, Cardiac and Vascular Function |
|
|
| Recruiting | N/A | 30 | Europe | Olivomed (capsules containing hydroxytyrosol), placebo soft capsules, OlivomedSmart - Capsules containing - combination of Oleuropein (OL), Hydroxytyrosol (HT), Oleocanthal (OC) - (OL:HT:OC 2:1:3), (5 mg HT bid). | University of Athens | Coronary Artery Disease | 04/25 | 08/26 | | |
NCT05185934: The Effect of Dietary Intervation on Endothelial Glycocalyx in COVID-19 Patients. |
|
|
| Recruiting | N/A | 60 | Europe | Food supplement Endocalyx, Placebo | University of Athens | COVID-19, Endothelial Dysfunction | 11/23 | 01/24 | | |
NCT05184699: The Effect of Dietary Intervention on Endothelial Glycocalyx in Psoriasis |
|
|
| Recruiting | N/A | 60 | Europe | Food supplement Endocalyx, Endocalyx, Q-prime, Placebo | University of Athens | Psoriasis | 11/23 | 01/24 | | |
NCT03878706: The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination |
|
|
| Recruiting | N/A | 240 | Europe | | University of Athens | Diabetes Mellitus, Type 2 | 12/26 | 06/27 | | |
NCT04966845: Effect of Face Mask on Exhaled Carbon Monoxide of Smokers |
|
|
| Completed | N/A | 120 | Europe | measurement of concentration on exhaled Carbon Monoxide | University of Athens | Concentration of Exhaled Carbon Monoxide | 07/21 | 07/21 | | |
| Iliodromitis, Efstathios |
NCT03878706: The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination |
|
|
| Recruiting | N/A | 240 | Europe | | University of Athens | Diabetes Mellitus, Type 2 | 12/26 | 06/27 | | |
| Recruiting | N/A | 675 | Europe | Implantable Cardioverter Defibrillator (ICD) insertion | University of Athens | Sudden Cardiac Death Due to Cardiac Arrhythmia, Dilated Cardiomyopathy | 05/25 | 05/25 | | |
| Kalogeris, Aimilianos N |
NCT03878706: The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination |
|
|
| Recruiting | N/A | 240 | Europe | | University of Athens | Diabetes Mellitus, Type 2 | 12/26 | 06/27 | | |
| Thymis, John A |
NCT03878706: The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination |
|
|
| Recruiting | N/A | 240 | Europe | | University of Athens | Diabetes Mellitus, Type 2 | 12/26 | 06/27 | | |
| Papadavid, Evangelia |
| Active, not recruiting | 2 | 72 | Europe, Canada, US, RoW | Placebo/Daxdilimab, Daxdilimab, HZN-7734 | Amgen, Horizon Therapeutics Ireland DAC | Discoid Lupus Erythematosus | 09/25 | 09/25 | | |
MOGAT, NCT04128072 / 2019-004566-17: Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma |
|
|
| Recruiting | 2 | 43 | Europe | Mogamulizumab, Total Skin Electron Beam Therapy (TSEB), Mogamulizumab (subsequent cycles post TSEB) | European Organisation for Research and Treatment of Cancer - EORTC | Stage IB-IIB Cutaneous T-Cell Lymphoma | 10/26 | 01/27 | | |
NCT04469582: The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors |
|
|
| Active, not recruiting | N/A | 113 | Europe | | University of Athens | Bullous Pemphigoid | 09/20 | 12/20 | | |
| Recruiting | N/A | 40 | Europe | | National and Kapodistrian University of Athens, Recordati Rare Diseases | Mycosis Fungoides | 02/25 | 12/25 | | |
| Recruiting | N/A | 4975 | Europe, RoW | RP-1828 IMMUcan, RP-1759 AYA/TYA, RP-1843 Arcagen, RP-1920 BioRadon | European Organisation for Research and Treatment of Cancer - EORTC | All Tumor Types | 03/26 | 03/26 | | |
| Kountouri, Aikaterini |
NCT04469582: The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors |
|
|
| Active, not recruiting | N/A | 113 | Europe | | University of Athens | Bullous Pemphigoid | 09/20 | 12/20 | | |
| Korakas, Emmanouil |
NCT04469582: The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors |
|
|
| Active, not recruiting | N/A | 113 | Europe | | University of Athens | Bullous Pemphigoid | 09/20 | 12/20 | | |
| Theotokoglou, Sofia |
NCT04469582: The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors |
|
|
| Active, not recruiting | N/A | 113 | Europe | | University of Athens | Bullous Pemphigoid | 09/20 | 12/20 | | |
| Theodoropoulos, Konstantinos |
NCT04469582: The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors |
|
|
| Active, not recruiting | N/A | 113 | Europe | | University of Athens | Bullous Pemphigoid | 09/20 | 12/20 | | |
| Filippou, Panagiotis |
STELA, NCT06119100: Correlation of Ultrasonographic Lesion Type Characterization With Angioplasty Outcomes in Failing Dialysis AVFs |
|
|
| Recruiting | N/A | 200 | Europe | Ultrasound characterization of stenotic lesion type | Attikon Hospital | Dialysis Access Malfunction | 11/24 | 12/24 | | |
| Palialexis, Kostantinos |
STELA, NCT06119100: Correlation of Ultrasonographic Lesion Type Characterization With Angioplasty Outcomes in Failing Dialysis AVFs |
|
|
| Recruiting | N/A | 200 | Europe | Ultrasound characterization of stenotic lesion type | Attikon Hospital | Dialysis Access Malfunction | 11/24 | 12/24 | | |
| Karachaliou, Anastasia |
STELA, NCT06119100: Correlation of Ultrasonographic Lesion Type Characterization With Angioplasty Outcomes in Failing Dialysis AVFs |
|
|
| Recruiting | N/A | 200 | Europe | Ultrasound characterization of stenotic lesion type | Attikon Hospital | Dialysis Access Malfunction | 11/24 | 12/24 | | |
| Grigoriadis, Stavros |
STELA, NCT06119100: Correlation of Ultrasonographic Lesion Type Characterization With Angioplasty Outcomes in Failing Dialysis AVFs |
|
|
| Recruiting | N/A | 200 | Europe | Ultrasound characterization of stenotic lesion type | Attikon Hospital | Dialysis Access Malfunction | 11/24 | 12/24 | | |
